Showing results (11-20 of 135) with videos related to
Sort By:
Pageof 14
Chemotherapy Research and Practice|November 15, 2012
The use of epidermal growth factor receptor monoclonal antibodies in squamous cell carcinoma of the head and neckJeffery S Russell, A Dimitrios ColevasThe Oncologist|January 25, 2015
Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patientsJoshua J Gruber, A Dimitrios ColevasJournal of the National Comprehensive Cancer Network : JNCCN|June 4, 2011
Controversies in the locoregional management of head and neck cancerDavid M Brizel, William Lydiatt, A Dimitrios ColevasOral Oncology|August 19, 2024
Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC)Lova Sun, Roger B Cohen, A Dimitrios ColevasJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2007
Patient-reported outcomes and the evolution of adverse event reporting in oncologyAndy Trotti, A Dimitrios Colevas, Ann Setser, et al.JAMA Otolaryngology-- Head & Neck Surgery|October 18, 2019
Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck CancerAnirudh Saraswathula, Michelle M Chen, A Dimitrios Colevas, et al.Oral Oncology|August 18, 2018
Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient ageMichelle M Chen, A Dimitrios Colevas, Uchechukwu Megwalu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2021
Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity ReactionsOlivia M Lansinger, Savanna Biedermann, Zihuai He, et al.Radiologic Clinics of North America|November 13, 2025
Update on Imaging of Nasopharyngeal CarcinomaNancy J Fischbein, A Dimitrios Colevas, Quynh-Thu Le, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Survival After Definitive Chemoradiotherapy With Concurrent Cisplatin or Carboplatin for Head and Neck CancerMichael Xiang, A Dimitrios Colevas, F Christopher Holsinger, et al.Pageof 14